abrdn Life Sciences Investors

Research abrdn Life Sciences Investors (HQL) on Bullrun: dividend yield 10.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHQL
• ExchangeNYSE
• CountryUnited States
• SectorFinancial Services
• IndustryAsset Management
• CurrencyUSD
• Dividend yield10.3%
• Financial periodQ3 2025
• RevenueUSD 86.39M
• Net incomeUSD 85.59M
• Free cash flowUSD 31.71M

Valuation Snapshot

dividend yield is 10.3%.

About abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.

Frequently asked questions

Does abrdn Life Sciences Investors pay a dividend?

abrdn Life Sciences Investors has a dividend yield of 10.3%.

What does abrdn Life Sciences Investors do?

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.